Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model
Crossref DOI link: https://doi.org/10.1007/s00262-022-03342-x
Published Online: 2022-12-26
Published Print: 2023-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Qiao, Tianyun
Zhao, Jinbo
Xin, Xiangbing
Xiong, Yanlu
Guo, Wenwen
Meng, Fancheng
Li, Hui
Feng, Yangbo
Xu, Hui
Shi, Changhong
Han, Yong
Text and Data Mining valid from 2022-12-26
Version of Record valid from 2022-12-26
Article History
First Online: 26 December 2022